Related Experiment Video
Updated: Feb 28, 2026

07:07
Determining Glucose Metabolism Kinetics Using 18F-FDG Micro-PET/CT
Published on: May 2, 2017
14.4K
PEERing into the Future: Benchmarking the ANSTO Australian Synchrotron's Very-High-Energy Electron Linac for
James Cayley1, Elette Engels1,2,3, Tessa Charles2
1Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW 2522, Australia.
Cancers
|February 27, 2026
Summary
The PEER beamline at the Australian Synchrotron is validated for Very High Energy Electron (VHEE) ultra-high dose rate (UHDR) FLASH radiotherapy studies. Biological benchmarking confirms its suitability for future in vivo investigations.
Area of Science:
- Medical physics and radiation oncology
- Accelerator science and technology
- Radiobiology
Background:
- The Australian Synchrotron's PEER beamline was developed for Very High Energy Electron (VHEE) FLASH radiotherapy research.
- It features a 100 MeV electron linac capable of ultra-high dose rates (up to 109 Gy/s).
- Biological benchmarking was essential to confirm the beamline's suitability for VHEE FLASH studies.
Purpose of the Study:
- To biologically benchmark the PEER beamline for VHEE FLASH radiotherapy.
- To assess the feasibility of small animal experiments using the PEER beamline.
- To compare VHEE FLASH cell survival data with other facilities.
Main Methods:
- Irradiation of three cell lines using real-time dosimetry to generate linear quadratic cell survival curves.
- Irradiation of mouse cadavers to simulate live animal experiments and assess logistics.
- Comparison of results with data from other VHEE facilities and conventional dose-rate irradiations.
Main Results:
- PEER beamline cell survival data aligned with VHEE results from DESY's ARES beamline.
- VHEE FLASH demonstrated enhanced cell sparing compared to conventional 2 Gy/s X-rays.
- Mouse cadaver irradiations confirmed safe and efficient small animal handling and irradiation procedures.
Conclusions:
- The PEER beamline is validated for VHEE UHDR FLASH radiotherapy research.
- Key capabilities include real-time dosimetry, repeatable alignment, and linac diagnostics.
- The beamline is suitable for future in vivo VHEE UHDR FLASH radiotherapy investigations.